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Abstract
Osteopontin is known to play important roles in various diseases including vascular disorders. However, little is known
about its expression and function in vascular adventitial fibroblasts. Adventitial fibroblasts have been shown to play a key
role in pathological vascular remodeling associating with various vascular disorders. In this study, we measured activation of
Osteopontin and its biological functions in cultured adventitial fibroblasts and injured rat carotid injury arteries induced by
balloon angioplasty. Our results showed that angiotensin II and aldosterone increased Osteopontin expression in adventitial
fibroblasts in a time- and concentration-dependent manner. MAPKs and AP-1 pathways were involved in Osteopontin
upregulation. In addition, Adventitial fibroblast migration stimulated by Angiotensin II and aldosterone required OPN
expression. Perivascular delivery of antisense oligonucleotide for Osteopontin suppressed neointimal formation post-injury.
We concluded that upregulation of Osteopontin expression in adventitial fibroblasts might be important in the
pathogenesis of vascular remodeling after arterial injury.
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Introduction
Osteopontin (OPN) an acidic and secreted glycoprotein plays
various roles in bone morphogenesis, cell transformation, immune
cell activation, and bacterial resistance [1,2,3,4]. Recently, it has
been found that the expression of OPN is involved in vascular
inflammatory response [5,6,7]. However, the expression and
function of OPN in adventitial fibroblasts is unknown.
Recently, there is emerging evidence that adventitial fibroblasts
play a vital role in neointimal formation [8,9,10,11,12]. It is believe
that endothelium damage induces the expression of growth factors,
cytokines, chemoattractants, which promotes early adventitial
activation and neointima formation [13]. Our previous study
indicated that TGFb1 triggered differentiation of vascular adven-
titial fibroblasts to myofibroblasts and the up-regulation of protein
kinase Ca was involved in this differentiation [14]. Recently, we
reported that angiotensin II (Ang II), phorbol ester, basic fibroblast
growth factor, and vascular endothelial growth factor (VEGF)
induced migration of adventitial fibroblasts [12,15]. Interestingly,
we found that Osteopontin augments migratory ability of culture
cells from spontaneously hypertensive rats, although the mecha-
nisms are not yet clear[16]. The renin–angiotensin–aldosterone
system is now implicated in the development of hypertensive
vascular and vascular remodeling disease, there is evidence for
aldosterone (ALD) and angiotensin II impair endothelium-related
vasodilatation and contribute to inflammation and vascular and
cardiac remodeling[17,18].
Therefore, we hypothesize that OPN is upregulated in vascular
advential by renin-angiotensin-aldosterone system, which thus
plays an important role in neointima formation. To test this
hypothesis, we determined whether the expression of OPN in
vascular adventitial fibroblasts was induced by Ang II or ALD and
then we investigated the role of OPN in neointima formation using
OPN antisense oligo, we also examined the signaling pathways
involved in OPN induction in vascular adventitial fibroblasts.
Results
1. OPN expression was regulated by Ang II and ALD in
vascular adventitial fibroblasts
To investigate the effects of Ang II and ALD on OPN
expression, adventitial fibroblasts were treated with various doses
of Ang II and ALD. First, we examined the effect of Ang II on the
expression of OPN. As shown in Fig. 1A, Ang II induced OPN
expression in a dose-dependent manner, with the maximal effect
observed at 10
27 mol/L Ang II. Ang II also induced the OPN
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24 h (Fig. 1B). We next examined whether the increase in OPN
protein expression by Ang II resulted from the induction of OPN
mRNA expression, We found that Ang II time-dependently
induced OPN mRNA in adventitial fibroblasts as assessed by real-
time reverse transcription polymerase chain reaction (RT-PCR)
(Fig. 1C), OPN mRNA was significantly increased within 6 h,
peaked by 12 h, and remained up to 48 h. To further determine
the role of Ang II receptors in OPN expression, adventitial
fibroblasts were pretreated with the specific angiotensin II type 1
(AT1) receptor blocker losartan (10
24 mol/L) or the angiotensin II
type 2 (AT2) receptor blocker PD 123319 (10
24 mol/L) for
30 min, and then the cells were exposed to Ang II (10
27 mol/L)
for 24 h. We found that the AT1 receptor blocker losartan but not
AT2 receptor blocker PD 123319 significantly blocked the effect of
Ang II on OPN protein expression (Fig. 1D). These indicate that
Ang II induces OPN expression through AT1 receptor.
Similarly, ALD also induced OPN expression in a dose-
dependent manner, with the maximal effect observed at
10
28 mol/L concentration of ALD (Fig. 1E). ALD also induced
the OPN expression in a time-dependent manner, with the
maximal effect of ALD observed at 24 h (Fig. 1F).
2. Mitogen-activated protein kinases (MAPKs) were
involved in OPN Expression
WepreviouslyshowedthatAngIIactivatesMAPKsinadventitial
fibroblasts [19]. Therefore, we examined whether the MAPK
activation was involved in Ang II–induced OPN expression in
adventitial fibroblasts. Pretreatment with a JNK1/2 inhibitor
SP600125 (20 mM), p42/p44 MAPK inhibitor PD98059 (20 mM)
for 1.5 h significantly blocked Ang II -induced OPN protein
expression (Fig. 2A). In contrast, pretreatment with a p38 MAPK
inhibitor SB203580 did not blocked Ang II-induced OPN
expression. These results suggest that Ang II induced OPN
expression via a JNK and p42/p44 signaling pathway in adventitial
fibroblasts.
Differently, pretreatment with a JNK1/2 inhibitor SP600125
(20 mM), p42/p44 MAPK inhibitor PD98059 (20 mM), p38
MAPK inhibitor SB203580 for 1.5 h significantly blocked ALD-
induced OPN protein expression (Fig. 2B). We also found ALD
antagonist spironolactone (Spir) not only inhibit ALD-induced
OPN protein expression but also blocked Ang II -induced OPN
protein expression by AT2 receptor. Since Ang II induce ALD
secretion by AT2 receptor in some cell type [20,21], Ang II and
ALD synergistically induced OPN protein expression in adventitial
fibroblasts, and Spir block the effect of ALD.
3. AP-1 was involved in OPN Gene Upregulation
To define the transcription factor that mediates Ang II-induced
OPN expression, we focused on AP-1 (c-Fos/c-Jun), we found that
cells transfected with c-Fos or c-Jun siRNA significantly reduced
c-Fos or c-Jun proteins, respectively (Fig. 3A). Downregualtion of
c-Fos or c-Jun by siRNA attenuated Ang II-induced OPN
expression at the levels of both mRNA (Fig. 3B) and protein
(Fig. 3C). This demonstrates that AP-1 (i.e. c-Fos and c-Jun) is
essential for mediating Ang II-induced OPN expression in
adventitial fibroblasts.
We next determined if Ang II induces c-Fos/c-Jun expression in
adventitial fibroblasts. As shown in Fig. 4A, Ang II markedly
induced c-Jun/c-Fos protein, with peaked within 1 h and
remained up to 2 h as assessed by Western blot. To further
determine whether Ang II-stimulated JNK activation leads to c-
Jun phosphorylation, we found that Ang II stimulated the c-Jun
phosphorylation, with peaked at 1 h (Fig. 4A). This was inhibited
by JNK inhibitor (SP600125) but not by ERK1/2 inhibitor
(PD98059) (Fig. 4B).
These results indicate that Ang II induced an immediate early
gene c-Jun expression and also activation through a JNK-
dependent pathway, thereby leading to OPN expression in
adventitial fibroblasts.
To definitively determine the role of AP-1 in regulation of OPN
transcription, we first determined whether AP-1-dependent tran-
scriptional activity was induced by Ang II in adventitial fibroblasts
using pAP-1-Luc reporter construct and luciferase analysis. As
shown in Fig. 5A, Ang II enhanced AP-1-dependent transcriptional
activity, which was inhibited by c-Fos or c-Jun siRNA.
We next determined whether Ang II induced the binding of c-Jun
and c-Fos to the OPN Promoter in vitro by gel shifting analysis. We
designed the biotin labeled AP-1 probes (59- TTC CGGCTGACT-
CATCAAGCG - 39 biotin) based on the AP-1 binding site sequence
(-76) located in the mouse OPN promoter. Nuclear extracts from
adventitial fibroblasts treated with Ang II for indicated time were
incubated with AP-1 probe, and AP-1 DNA complex was detected
by gel electrophoresis. We found that Ang II induced AP-1 DNA
complex formation in a time dependent manner (Fig. 5B). The
specificity of the AP-1 binding was determined by competition
experiments with excess of unlabeled oligonucleotide containing the
AP-1 binding site (Fig. 5B, lane4) Furthermore, we determined
whether Ang II induced AP-1 binding to OPN promoter in vivo
using chromatin immunoprecipitation (ChIP)-PCR. Chromatin was
immunoprecipitated using an anti-c-Fos or anti-c-Jun antibody, and
the OPN promoter region was amplified by PCR using a pair of
primers encompassing an AP-1 binding site (-76) in OPN promoter.
As shown in Fig. 5C, in vivo binding of c-Jun/c-Fos to the OPN
promoter was increased upon Ang II stimulation. Together, these
resultsdemonstratethatAngIIindeedinducedthebindingactivityof
c-Fosandc-JuntotheAP-1siteinthe promoterregionofOPNgene.
4. OPN is critical for Ang II and ALD-induced adventitial
fibroblast migration
Our previous study has shown that Ang II and ALD increased
adventitial fibroblasts migration [12], to determine if the migration
of adventitial fibroblasts is OPN-dependent, migration experiments
with Ang II and ALD were performed. As shown in Fig 6A and B,
Figure 1. Increase in OPN in adventitial fibroblasts by Ang II and ALD. (A) Ang II-induced expression of OPN protein in a dose-dependent
manner. The effect of Ang II on OPN expression was observed at 24 h, the concentration for maximal effect of Ang II was observed at 10
27 mol/L. (B)
the effects of Ang II on adventitial fibroblasts expression were time-dependent. The effect of Ang II on OPN expression was observed at 10
27 mol/L.
The maximal effect of Ang II on OPN expression was observed at 24 h. (C) Adventitial fibroblasts were treated with Ang II (10
27 mol/L) for varying
amounts of time following serum deprivation for 48 h. OPN mRNA levels were quantified by real-time RT-PCR and were normalized to b-actin mRNA
levels. (D) The effects of Ang II on OPN expression were blocked by the AT1 receptor blocker losartan, whereas the AT2 receptor blocker PD 123,319
had no effect. The gels represent results of 3 independently performed experiments. (E) ALD -induced expression of OPN protein in a dose-
dependent manner. The effect of ALD on OPN expression was observed at 24 h. The concentration for maximal effect of Ang II was observed at
10
28 mol/L. (F) the effects of ALD on adventitial fibroblasts expression were time-dependent. The concentration for effect of Ang II was observed at
10
28 mol/L. The maximal effect of ALD on OPN expression was observed at 24 h. Normalized data (bar graphs) are presented as mean 6 SEM.
*P ,0.05 vs. adventitial fibroblasts in DMEM alone (control), ** P,0.05 vs. adventitial fibroblasts in Ang II alone.
doi:10.1371/journal.pone.0023558.g001
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transwell chamber. OPN anti-sense significantly attenuated Ang II
or ALD-induced adventitial fibroblasts migration, while OPN sense
or scramble sense cannot inhibit ALD or Ang II-induced adventitial
fibroblasts migration, demonstrating that OPN is essential for Ang
II or ALD-induced migration in adventitial fibroblasts. To
determine if the migration of adventitial fibroblasts is also AP-1-
dependent, migration experiments with Ang II were performed in
the presence of siRNA of c-Fos or c-Jun. As shown in Fig. 6C, Ang
II significantly increased migration measured by transwell chamber.
C-Fos or c-Jun siRNA significantly attenuated Ang II-induced
adventitial fibroblasts migration, demonstrating that AP-1 (i.e. c-Fos
and c-Jun) is essential for Ang II-induced migration in adventitial
fibroblasts. We also found OPN neutralize antibody attenuated Ang
II-induced adventitial fibroblasts migration.
5. OPN was involved in neointimal hyperplasia after
balloon injury
We determine the role of OPN in neointimal hyperplasia after
balloon injury using perivascularly applied OPN antisense oligo.
We first examined OPN expression by Western blotting analysis.
Taking adventitial layer from vascular layers, as shown in Fig. 7A,
balloon injury dramatically increased the OPN protein level in the
adventitial layer of rat carotid arteries, which is significantly
attenuated in the arteries treated with OPN antisense oligo. This
indicates that perivascular application of OPN antisense oligo
effectively prevented OPN upregulation after injury.
We then examined the expression of OPN in both neointima and
adventitia of rat carotid arteries after balloon injury by immuno-
fluorescent assay. As shown in Fig 7B (panel b versus panel a), in
compare to sham-operation group, OPN immunostaining increased
in the neointima, media, and adventitia on day 14, which was
attenuated in the adventitial layers of the arteries treated with OPN
antisense oligo compared with sense oligo (Fig 7B, panel c versus
panels d and b). To monitor the effect of MAPKs on OPN
expression in vivo, carotid arteries were treated with SP600125 by
adventitial administration in vivo, as shown in Fig 7B(panel e versus
panels b and f), SP600125 delivery to the adventitia inhibited
markedly OPN expression in vivo after balloon catheter injury
compared to dimethyl sulfoxide (DMSO) group.
We then evaluated the effects of OPN antisense oligo on
vascular remodeling. As shown in Fig. 8A, neointima formation at
Figure 2. MAPK pathways were involved in OPN expression in Adventitial fibroblasts. (A) Cells were preincubated with 20 mM PD98059,
SB203580, SP600125 for 1.5 h and then treated with 10
27 mol/L Ang II for 12 h. (B) Cells were treated with ALD(10
28 mol/L), Ang II (10
27 mol/L)
alone or along with Spir, losartan or PD 123,319 for 24 h. Then cells were preincubated with 20 mM PD98059, SB203580, SP600125 for 1.5 h and then
treated with 10
28 mol/L ALD for 24 h. OPN expression was determined by Western blotting analysis. The gels represent results of 3 independently
performed experiments. Normalized data (bar graphs) are presented as mean 6 SEM. *P ,0.05 vs. adventitial fibroblasts in Ang II and ALD alone.
** P,0.05 vs. adventitial fibroblasts in DMEM. # P,0.05 vs. adventitial fibroblasts in Ang II. $ P,0.05 vs. adventitial fibroblasts in ALD.
doi:10.1371/journal.pone.0023558.g002
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with OPN antisense oligo compared with sense oligo (Fig. 8A,
panels c versus panels a and b). The quantitative data were shown
in Fig. 8B. The neointimal area at 28 days after the injury was
0.1260.06 mm
2 in antisense-OPN-treated arteries, and signifi-
cantly smaller than the corresponding area in injured arteries
treated by sense-OPN or vehicle (0.2760.07 mm
2, p,0.05). The
antisense-OPN also decreased the I/M area in arteries compared
with sense-OPN or vehicle treated arteries (0.6760.31 vs.
1.5760.34, p,0.05).
6. OPN influence fibroblast function through MAPKs
pathway
We then explored the potential molecular pathways involved in
fibroblast activation by OPN. As shown in Fig 9A and B (panels b
versus panels a), compared with the sham-operation group, the
aortic wall at the lesion sites showed enhanced expression of
phospho-ERK1/2 and phospho-p38. In contrast, the expression
level of phospho-ERK1/2 was reduced at both the adventitial and
neointimal layers of the arteries treated with OPN antisense oligo
compared with sense oligo and catheter injury group (Fig 9A,
panels c versus panels b and d). Similarly, the expression level of
phospho-p38 was lower in the neointimal layer of the arteries
treated with OPN antisense oligo compared with sense oligo and
catheter injury group (Fig 9B, panel c versus panels b and d).
Discussion
Several previous studies have shown that OPN plays an
important role in cardiovascular disease, such as myocardial
ischemia/hypoxia, cardiac valve formation and vascular inflam-
mation, and remodeling [22,23,24,25,26,27,28,29,30,31,32].
While OPN regulation has been studied in several different cell
types [32,33,34,35], its role and regulation in vascular adventitial
fibroblasts have never been evaluated.
In the present studies we used the in vivo balloon-injured rat
carotid artery model and demonstrated OPN expression in
adventitial after injury. Adventitial transduction of antisense oligo
targeting OPN attenuated injury-induced OPN upregulation,
inhibited adventitial fibroblasts migration, and prevented neoi-
nitma formation. In addition, MAPK and AP-1 pathways were
involved in the regulation of OPN. Based on these results, we
conclude that growth factors such as Ang II and ALD mediated
regulation of OPN are an important mechanism responsible for
regulation of adventitial fibroblast migration and subsequent
neointima formation.
Over the past decade increasing evidence suggests an important
role for the adventitia in certain physiological and pathological
conditions [36,37,38,39]. Our previous studies have suggested that
perivascular transfer of exogenous genes primarily affected
adventitial but not vascular smooth muscle cells or endothelial
cells [40]. OPN antisense oligo applied perivascularly reduced
neointima formation, with also supports an important role of
adventitial in regulating neointimal hyperplasia and vascular
remodeling. In addition, compared with other intraluminal
catheter delivery approach, perivascular transfer has the advan-
tages of preventing rapid development of neointimal lesions.
Upregulation of OPN has been described in models of cardiac
hypertrophy and heart failure, and MAPK and AP-1 appear to be
important. In our study, we firstly found that JNK activation is
required in OPN expression by Ang II and ALD in aortic
adventitial fibroblasts.
The AP-1 transcription factor consists of a large set of dimers
containing Jun, FOS, and ATF families of proteins. They contain
transactivation domains, DNA-binding domains, and leucine
zippers [41,42,43]. Sharma et al have shown Ang II induce c-
jun and c-fos mRNA expression [44]. In this study, we
demonstrate that Ang II increased c-Jun phosphorylation and
thus activation, which was attenuated by pretreatment with
inhibitors of JNK. Interestingly, inhibitors of JNK do not inhibit
Ang II-induced c-Fos expression while it inhibits Ang II-induced
migration; this result is consisted with other studies [45,46]. Our
data also showed that Ang II stimulates AP-1 transcription activity
(either c-Jun or c-Fos), which acts as an important mediator in
OPN upregulation and adventitial fibroblasts migration.
To further examine whether AP-1 binds to AP-1 sites in the
promoter region of OPN gene, the binding activity of AP-1 was
determined by EMSA and ChIP-PCR assay. Our data showed
that Ang II up-regulates OPN expression through stimulating c-
Jun and c-Fos binding to the -76AP-1 site.
OPN-dependent fibroblast activation in our balloon injury
model may be via both a direct and an indirect effect of OPN on
adventitial fibroblasts. Evidence in support of a direct role for
OPN is that OPN anti-sense attenuated Ang II or ALD-induced
adventitial fibroblasts migration, as well as our previous studies
that demonstrate a direct effect for OPN on fibroblasts in vitro
including enhanced migration and proliferation[16]. Other studies
have also confirmed the direct activatory role for OPN on cardiac
fibroblasts [47]. OPN may also activate vascular fibroblasts
indirectly via activating MAPK pathway. Our findings support
this: first, the injury aortic wall increase the expression of phospho-
ERK1/2, and phospho-p38, while OPN antisense treated injury
rats show reduced expression of phospho-ERK1/2 and phospho-
p38 in aortic wall. Second, activation of the MAPK pathway has
an impact on the vascular remodeling in vivo, for MAPK pathway
have many targets in the downstream, including connective tissue
growth factor, VEGF, and many others. These moleculars may
have an impact on the vascular remodeling. We use MAPKs
pathway inhibitor also inhibit the neointimal hyperplasia in vivo
(Figure S1). Until now, which downstream target remain
unknown, it requires extensive investigation.
Recent evidence indicates the presence of progenitor cells in the
adventitial [48,49,50,51,52,53,54,55,56]. Kaplan et al [57] show
that Flt-1 was used to identify progenitors; our previous study
showed that Flt-1 expression was significantly increased in the
neointima and adventitia in injured rat carotid arteries [15]. Many
other studies showed osteopontin have an impact on the
progenitor activities such as proliferation, migration, and angio-
genesis [58,59,60]. Together, these data indicate another potential
mechanism for the role of OPN in vascular remolding: stem cells
could be induced by OPN at adventitia after injury and migrate to
the neointima, which contribute to the neointimal hyperplasia
response to injury.
Figure 3. Upregulation of OPN protein(C) and mRNA (B) expression mediated through AP-1 (c-Fos/c-Jun) pathway in Adventitial
fibroblasts. (A) Adventitial fibroblasts were transfected with c-Fos, c-Jun siRNA or Control-siRNA, and then stimulated with Ang II (10
27 mol/L) for
1 h. The protein of c-Jun or c-fos was assayed by Western blot. (B) Adventitial fibroblasts were transfected with c-Fos, c-Jun siRNA or Control-siRNA,
and then stimulated with Ang II (10
27 mol/L) for 10 h. The mRNA of OPN was assayed by RT-PCR. (C) Adventitial fibroblasts were transfected with
c-Fos, c-Jun siRNA or Control-siRNA, and then stimulated with Ang II (10
27 mol/L) for 12 h. The protein of OPN was assayed by Western blot. (D)
doi:10.1371/journal.pone.0023558.g003
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PLoS ONE | www.plosone.org 7 September 2011 | Volume 6 | Issue 9 | e23558In summary, our in vitro and in vivo studies demonstrated an
increased expression of OPN in adventitial fibroblasts in response
to growth factors such as Ang II and ALD. By using antisense oligo
of OPN, we indicated that OPN promotes adventitial fibroblasts
migration in vitro and contributes to vascular remodeling after
balloon injury in vivo. Our data also suggest that OPN may serve
as potential candidates for treating neointimal hyperplasia via AP-
1 signaling.
Figure 4. Ang II induced AP-1 activity. (A) Adventitial fibroblasts were treated with Ang II (10
27 mol/L) at the indicated time, the protein
expression of c-Jun and c-Fos and the phospharylation levels of c-Jun (ser63, ser73) were identified. (B). Effect of PD98059, SB203580, SP600125 on
Ang II-induced AP-1 expression and phospharylation, cells were pretreated with 20 mM PD98059, SB203580, SP600125 for 1.5 h and then incubated
with 10
27 mol/L Ang II. The intensities of bands were quantified. The gels represent results of 3 independently performed experiments. Normalized
data (bar graphs) are presented as mean 6 SEM. *P ,0.05 vs. adventitial fibroblasts in DMEM alone. ** P,0.05 vs. adventitial fibroblasts in Ang II
alone.
doi:10.1371/journal.pone.0023558.g004
Figure 5. Ang II induced c-Jun and c-Fos DNA binding activity. (A) Adventitial fibroblasts were co-transfected with pAP-1-Luc and 0.2 mgo f
b-Gal luciferase reporter control vector in the absence or presence of siRNA for c-Jun or c-Fos. Twenty-four hours after transfection, the cells were
treated with Ang II (10
27 mol/L) for 1 h, the cells were lysed and luciferase activities were measured. (B) Adventitial fibroblasts were treated with
10
27 mol/L Ang II at different time and the nuclear extracts were prepared. Gel-shift assays were performed. The specific shifted AP1 components are
indicated by arrows. (C) Cells were cross-linked with 1% formaldehyde; nuclear lysate was then prepared. After precipitation with different anti-c-Jun,
c-Fos antibodies or normal goat serum, the OPN promoter regions were amplified by PCR, respectively. The gels represent results of 3 independently
performed experiments. *P ,0.05 adventitial fibroblasts were transfected with siRNA for c-Jun or c-fos vs. control-siRNA, ** P,0.05 adventitial
fibroblasts in Ang II vs. DMEM alone.
doi:10.1371/journal.pone.0023558.g005
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1. Materials
The study was approved by the Institutional Review Board of
Shanghai Institutes for Biological Sciences of Chinese Academy of
Sciences. All experimental protocols were approved by the Animal
Care and Use Committee of Shanghai Institutes for Biological
Sciences of Chinese Academy of Sciences, the approval numbers
for this study is 2003136. Ang II and PD 123319 were obtained
from Sigma-Aldrich (St. Louis, Missouri, USA). Losartan was
kindly provided by Merck (Rahway, New Jersey, USA). Anti-c-
Jun, anti-c-Fos, anti-Phospho-c-Jun (Ser63), anti-Phospho-c-Jun
(Ser73) antibodies were purchased from Cell Signaling Technol-
ogy (Cell Signaling, CA, USA), b-Actin was purchased from
Sigma– Aldrich (St. Louis, Missouri, USA). The neutralizing OPN
antibody was purchased from R&D Systems (Minneapolis, MN,
USA). SiRNA-c-Jun, siRNA-c-Fos was purchased from Santa
Cruz (Santa Cruz, CA, USA).
2. Cell culture
The isolation and culture of adventitial fibroblasts from thoracic
aorta of 12–14-week-old male Sprague–Dawley rats were similar
to previously described [61,62]. Briefly, thoracic aortas were
removed and stripped of perivascular connective tissue; the media
and endothelium were separated from the adventitia. Then the
dissected adventitia was cut in to pieces and planted on dishes.
These cells were characterized by positive staining for vimentin,
and negative staining for a-SM-actin as described previously [14].
3. Synthesis of Antisense Oligonucleotides
Phosphorothioate-derived oligodeoxynucleotides was chemically
synthesized by MWG Biotech AG (Germany) and was comprised of
the following sequences: OPN antisense 59-AACCACTGC-
CAGTCTCAT-39, OPN sense: 59-ATGAGACTGGCAGTG-
GTT-39, OPN scramble sense: 59-AACTACTATCAGTCTCGT-
39. The OPN sense oligodeoxynucleotide sequence comprised the
first five codons of rat OPN mRNA, and antisense OPN
oligodeoxynucleotides comprised the complementary sequence.
4. Western blotting
Whole cell extracts were prepared essentially as before [42].
The samples were then resolved on polyacrylamide gels containing
SDS and transferred to a nitrocellulose membrane by electroblot-
ting. The membrane was incubated in blocking buffer (TBS
Containing 5% skim milk and 0.1%Tween20) for 2 h, followed by
incubation with the primary antibody diluted in the same buffer.
The specific secondary antibody was detected using peroxidase-
conjugated anti-IgG at 1:2000. Relative proteins were detected by
the supersignal chemiluminescence system (ECL, Pierce) followed
by exposure to autoradiographic film.
5. Electrophoresis mobility shift assay (EMSA)
For EMSA (LightShiftTM Chemiluminescent EMSA Kit,
Pierce), 5 mg of nuclear extract was incubated with 2 nmol/L of
the end-labeled with biotin double-stranded oligonucleotide
probes in reaction buffer for 20 min at room temperature.
Samples were resolved on a nondenaturing 4% polyacrylamide–
2% glycerol gel, transferred to BiodyneR B Nylon membrane,
avidin-HRP to probes, and visualized and quantitated with a
PhosphorImager. All the double stranded probes were synthesized
as follows: for the binding sites of AP-1 in the OPN promoter: 59-
CAA AAC CAG AGT GGG GAG TG-39(sense) and 59-CAA
AGC CAA GGA TGC TGA-39(anti-sense).
6. Migration assays
Evaluation of cell migration utilized a transwell cell culture
chamber inserts with 8.0-um pores (Corning Costar, Cambridge,
MA, USA) in 24-well plates as described previously [15].
Figure 6. Effect of anti-sense or neutralized antibody for OPN
and AP-1-siRNA on the migration of Adventitial fibroblasts. (A)
Adventitial fibroblasts were treated with Ang II (10
27 mol/L) for 8 h and
subsequently studied cells migration by using transwell apparatus. The
increased migration was blocked by treatment with anti-sense for OPN.
(B) Adventitial fibroblasts were treated with ALD (10
28 mol/L) for 8 h
and subsequently studied cells migration by using transwell apparatus.
The increased migration was blocked by treatment with ant-sense for
OPN. (C) Tranfected with siRNA for c-Jun or c-fos or pretreated with
neutralized antibody for OPN then adventitial fibroblasts were treated
with Ang II (10
27 mol/L) for 8 h and subsequently studied cells
migration by using transwell apparatus. Each bar represents mean 6 SE
of cell migrated per high- powermicroscope for three independent
experiments. *P ,0.05 vs. adventitial fibroblasts in DMEM alone. **
P,0.05 vs. adventitial fibroblasts in Ang II alone.
doi:10.1371/journal.pone.0023558.g006
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Transfections were performed with the SuperFect transfection
reagent (Qiagen, Hilden, Germany) method. Luciferase activity was
detected witha luciferase assaykit(Promega Corporation,Madison,
WI). Transfection of siRNA duplex was done following the
manufacturer9s protocol described at Santa Cruz Biotechnology,
Inc. (Santa Cruz, CA, USA).
8. Chromatin Immunoprecipitation Assay
ChIP assays were performed using the ChIP Assay Kit
(Millipore, Temecula, CA) and protocol described at www.
millipore.com (17-611). Briefly, quiescent adventitial fibroblasts
treated by 10
27 mol/L Ang II for 1 hour, cells were cross-linked
with 1% final concentration of formaldehyde at 37uC for 10 min
before harvest. The DNA was then isolated and sheared by
sonication. The proteins of interest were immunoprecipitated
along with the DNA to which it was bound using antibodies
specific for IgG, c-Jun and c-Fos (upstate), and then the cross-links
were reversed. Then, PCR was performed using the OPN gene
specific primers for AP-1 binding region, sense 59 - CAAAAC-
CAGAGTGGGGAGTG - 39 and antisense 59 – CAAAGCCA-
AGGATGCTGA - 39 primers. The Sp-1 gene fragment control
was amplified using 59- AGAACCGCACAGTCTCTGGT-39 and
59- GGGACAGCTTGCTGGAGTAG -39 primers.
Figure 7. Expression of OPN after rat carotid operation. (A) Expression of OPN after rat carotid injury. Adventitial separated from non-Injured
adventitial arteries, injured adventitial arteries or injured adventitial arteries for antisense OPN were assayed by westernblotting 28 days after carotid
injury. (B) OPN expression is demonstrated immunofluorescently in arterioc wall. a, Sham-operation ; b,operation injury 14 days; c, operation+anti-
sense OPN treated; d, operation+sense OPN treated; e, operation+sp600125; f, operation+DMSO. Scale bars represents 50 mm (E, Endothelium; M,
Medial; A, Adventitial).
doi:10.1371/journal.pone.0023558.g007
Osteopontin in Vascular Adventitial Fibroblasts
PLoS ONE | www.plosone.org 10 September 2011 | Volume 6 | Issue 9 | e235589. Quantitative Real-Time RT-PCR
OPN mRNA expression levels were determined by quantitative
real-time RT-PCR. Briefly, total RNA was isolated from
adventitial fibroblasts stimulated with and without Ang II, using
RNAzol reagent (invitrogen).
The real-time PCR was performed using SYBR Green Master
Mix and the ABI PRISM 7700 Sequence Detection System
(Applied Biosystems, Foster City, CA USA) according to the
manufacturer’s recommendations. The primer sequences used to
amplify b-actin mRNA were 59 -CCA GGC ACC AGG GCG
TGA TG-39 (sense) and 59-CGG CCA GCC AGG TCC AGA
CG- 39 (anti-sense); OPN mRNA 59-CAGTCGATGTCCCT-
GACGG-39 (sense) and 59-GTTGCTGTCCTGATCAGAGG-39
(anti-sense). Relative levels of OPN mRNA expression were
normalized in all the samples analyzed with respect to the levels of
b-actin amplification.
10. Perivascular delivery of antisense-OPN and SP600125
following rat carotid artery balloon injury
Male 12–14-week-old Sprague–Dawley rats weighing approx-
imately 350–400 g were used in the present study (6–8 rats per
group). Antisense-OPN or sense-OPN (as a negative control) was
Figure 8. OPN antisense inhibited neointima formation in injured carotid arteries. (A) Representative light micrographs of common
carotid arteries from Veh-, sense-OPN, and antisense-OPN treated rats at day 28 after balloon injury. Arterial sections were stained with HE stain. (B)
Effects of administration of antisense-OPN on neointima area and neointima/media ratio of injured carotid arteries in rats at 28 days after carotid
artery balloon injury. The results are taken from 3 rats per group and represent 3 independently performed experiments. Data are shown as
mean+SEM. $ P,0.05 vs. Veh group and sense-OPN. * P,0.05 vs. normal arterial adventitial layers. # P,0.05 vs. arterial adventitial layers at day 28
after balloon injury.
doi:10.1371/journal.pone.0023558.g008
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Immediately after the injury procedure, 200 ml of pluronic gel
containing the adenovirus was applied to the adventitial surface of
the artery. After solidification of the gel, the wound was closed and
the animals were allowed to recover from the anesthesia. The rats
were killed within 28 days after the balloon injury and their
common carotid arteries were excised for histological or Western
blot analyses.). For SP600125, 100 mmol/L SP600125 and 1%
DMSO (as a negative control) was suspended in pluronic F127 gel
(Sigma; 20% w/v in sterile saline). Immediately after the injury
procedure, 200 ml of pluronic gel containing the adenovirus was
applied to the adventitial surface of the artery. After solidification
of the gel, the wound was closed and the animals were allowed to
recover from the anesthesia. The rats were killed within 14 days
after the balloon injury and their common carotid arteries were
fixed by perfusion with 4% (w/v) polyformaldehyde.
11. Measurement of luminal narrowing of the injured
arteries
The common carotid arteries were fixed by perfusion with 4%
(w/v) polyformaldehyde for 15 min under constant pressure. The
fixed arteries were then removed, embedded in paraffin and
sectioned at 5-mm thickness. Cross-sections were stained with
hematoxylin and eosin. The neointimal and medial areas of each
cross-section were measured with a light microscope (Zeiss
AxioSkop 20) connected to an image analyzer, and the intima/
medium (I/M) area ratio was calculated.
12. Immunohistochemical and immunofluorescence
analyses
For each time point, corresponding tissue sections were
deparaffinized. After quenching endogenous peroxidase with
0.3% H2O2, nonspecific binding was blocked by incubation in
10% normal goat serum (NGS) for all primary antibodies. After
washing, primary antibodies were detected with a horseradish-
peroxidase-labeled secondary antibody. For immunofluorescence,
primary antibodies were detected with secondary antibody which
is labeled by AlexaFluor 568 (Invitrogen). Cellular nuclei were
stained with Hochest-33342 (1:5000) (Invitrogen). Analysis was
performed using a fluorescent microscope (Nikon, DXM1200F)
with a computerized, digital image analysis system and Adobe
PhotoShop software.
Supporting Information
Figure S1 Representative light micrographs of common
carotid arteries from sham-, Veh-,sense-OPN, sp600125-,
DMSO- and antisense-OPN treated rats at day 14 after
balloon injury. Arterial sections were stained with HE stain. a,
Sham-operation; b,operation injury 14 days; c, operation+anti-
sense OPN treated; d, operation+sense OPN treated; e, oper-
ation+sp600125; f, operation+DMSO. Scale bars represent
100 mm.
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